Cat.#: ASSD-122
Description | Fluorescent adrenoceptor β2 antagonist (apparent KD values are 8.87, 7.25 and 6.98 for β2, β1 and β3 respectively). Antagonizes the activity of isoprenaline, a non-selective β-adrenoceptor agonist. |
Synonyms | β2 -633-AN |
Size | 500 μg |
Applications | For imaging at β1 / β2 / β3 adrenoceptors use solutions up to 100 nM. |
Molecule Weight | 834 |
Purity | >97% |
Solubility | Soluble in DMSO |
Excitation | 633 nm |
Emission | 650 nm |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Important | We strongly recommend storing this product away from light and briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-132 | Congo Red (AC132) | 100 mg, 1g | inquiry |
ASSD-118 | BrdU (5-Bromo-2′-deoxyuridine) (AC118) | 200 mg, 100 mg, 1 g, 5g | inquiry |
ASSD-142 | Methoxy-X04 (AC142) | 10 mg, 50 mg | inquiry |
ASSD-136 | LUF7445/A2A antagonist (AC136) | 50 μg | inquiry |
ASSD-162 | Nile Red (AC162) | 25 mg | inquiry |
ASSD-121 | Fluorescent adenosine A3 antagonist [XAC] (AC121) | 500 μg | inquiry |
ASSD-146 | Pyronin Y (AC146) | 1 g, 5g | inquiry |
ASSD-215 | 1-Pyrenylmethyl Methanethiosulfonate (AC215) | 10 mg | inquiry |
ASSD-199 | 4,7-Dioxaoctylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[2-fluoro-4′-phosphophenylacetic Acid] Diamide (AC199) | 500 μg | inquiry |
ASSD-114 | Acridine Orange hydrochloride (AC114) | 50 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.